Título: Tissue in host engineering guided regeneration of arterial intimal.
Investigador principal UVa: José Carlos Rodríguez Cabello.
Programa I+D: FP7-HEALTH-2011-two-stage.
Fecha de inicio: 01/01/2012
Duración: 60 meses
Presupuesto: 6M€
Descripción: El proyecto tiene como objetivo diseñar y desarrollar un andamiaje bioactivo y bio-reabsorbible que regenera el crecimiento local después del tratamiento endovascular de las arterias obstruidas en pacientes con aterosclerosis.
Consorcio: Technical Proteins Nanotechnology SL, Donawa Lifescience Consulting SRL, Conic Vascular Technology SA, Universidad de Valladolid, The University of Liverpool, Fundació Privada Institut de Bioenginyeria de Catalunya, Universita degli Studi di Napoli Federico H., Universitair Medisch Centrum Utrecht.
En este sitio web de la Fundación General de la Universidad de Valladolid utilizamos cookies para personalizar los contenidos, proporcionar funcionalidades a nuestras redes sociales y para analizar nuestro tráfico. Para ello es necesario que nos autorices el uso de esta tecnología, pudiendo revocar tu consentimiento cuando lo desees. AceptoMás información
Política y privacidad de cookies
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Sorry, the comment form is closed at this time.